• Keloids and hypertrophic scars are characterized by excessive collagen formation. Interferon gamma is a lymphokine that can down-regulate collagen synthesis in vitro and in vivo and, therefore, has potential therapeutic benefit in the management of abnormal scars. Intralesional scar injections of interferon gamma were performed to determine the tolerance toxicity and to obtain preliminary evidence for the efficacy of this treatment in the management of hypertropic and keloid lesions. All scars decreased in linear dimensions and flattened out. Five of 10 scars studied decreased at least 50% in linear dimensions. Interferon gamma can safely be administered intralesionally once per week up to a dosage of 0.05 mg for 10 weeks with no serious toxic effects. The commonest reported side effect was a mild headache.
(Arch Otolaryngol Head Neck Surg. 1990;116:1159-1162)
Larrabee WF, East CA, Jaffe HS, Stephenson C, Peterson KE. Intralesional Interferon Gamma Treatment for Keloids and Hypertrophic Scars. Arch Otolaryngol Head Neck Surg. 1990;116(10):1159–1162. doi:10.1001/archotol.1990.01870100053011
Browse and subscribe to JAMA Network podcasts!
Customize your JAMA Network experience by selecting one or more topics from the list below.
Create a personal account or sign in to: